Page 134 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux
P. 134

2. MÉDICAMENTS DU DIABÈTE SUCRÉ UTILISABLES PAR VOIE ORALE   95


           Contrôles
           MENZER M., PREZEWOWSKI J. et HAUG U., Studies on the formation of by-products
             during tolbutamide synthesis using thin-layer chromatography. Pharmazie, 1971,
             26, 738-739.
           Sites de liaison
           ASHFORD M.L., Potassium channels and modulation of insulin sécrétion in Potassium
             channels : structure, classification, fonction and therapeutic potential, (COOK N.S.,
             edit.) ELUS HORWOOD, Chichester 1990, 300-319.
           GEISEN K., HITZEL V., OKOMONOPOULOS PUNTER J., WEYER R. et SUMM H.D.,
             Inhibition of 3H glibenclamide binding to sulphonylureas receptors by oral antidia-
             betics. Arzneimittel-Forschung/Drug res., 1985, 35, 707-712.
           GARRINO M.G. et HENQUIN J.C., Highly potent and stereoselctive effects of the ben-
             zoïc acid dérivative AZ-DF 265 on pancreatic b cells., Br. J. Pharmacol., 1988, 93,
             61-68.
           Canaux potassiques
           SCHMID-ANTOMARCHI H., de WEILLE J., Fosset M. et Lazdunski M., J. Biol. Chem.,
             1987, 262, 15840-15844.
           BERNARDI H., FOSSET M. et LAZDUNSKI M., Proc. Natl. Acad. Sci USA, 1988, 85,
             9816-9820.
           TAKAMOTO K., RÔKAEUS A.A., JÔRNVALL H., MAC DONALD T.J. et MUTT V., FEBS
             lett., 1983, 164, 124-128.
           QUAST U. et COOK N.S., Moving together : K+ channel openers and ATP-sentitive K+
             channels. Trends in pharmacological Sciences, 1989,10, 431-435.
           COOK N.S. et QUAST U., Potassium channel pharmacology in Potassium channels :
             structure, classification, fonction & therapeutic potential, COOK N.S. (edit.) Ellis
             Horwood, Chichester 1990, 181 -231.
           LAZDUNSKI M. Les canaux potassiques sensibles à l'ATP ou les suites imprévues de
             l'étude des sulfamides hypoglycémiants. Médecine/Sciences, 1990, 279-85.
           MILLE R. Glucose-regulated potassium channels are sweet news for neurobiologists.
             Trends in neurosciences, 1990,13, 197-199.
           ROBERTSON D.W. et STEINBERG M.I., Potassium channel modulators : scientific
             applications and therapeutic promise. J. Med. Chem., 1990, 33, 1529-1541.
           BARTFAI T., FISONE G. et LANGEL U., Galanin and galanin antagonists : molecular
             and biochemical perspectives. Trends in Pharmacological Sciences, 1992, 312-317.
           HOLZ G. et HABENER J.F. Signal transduction crosstalk in the endocrine System :
             pancreatic b-cells and the glucose compétence concept. Trends in biological
             Sciences,1992, 17, 388-391.
           DUNNE M.J. The physiology and pharmacology of ATP-regulated potassium channels
             in insulin secreting cells in potassium channels moderators. Pharmacological,
             molecular and clinical aspects, WESTON O.G. & HAMILTON T.C. (edit.) Blackwell
             Scientific Publication, Oxford, 1992, 110-143.
           Mode d'action
           PIPELEERS D., The biosociology of pancreatic B cells, Diabetologia, 1987, 30, 277-
             291.
   129   130   131   132   133   134   135   136   137   138   139